Browse All

Current Filters

CLEAR FILTER x

TITLE

Dietary Vitamin D Supplementation Mitigates Neuroinflammation in a Novel Mouse Model of Cerebral Demyelinating Adrenoleukodystrophy

Author:Van Haren, Keith   Kaushal, Esha   Hashemi, Ezzat   Han, May   

Session Name:S37: Emerging Therapies in Child Neurology  

Topic:Child Neurology and Developmental Neurology  

Program Number:S37.001  

Author Institution:Stanford University School of Medicine, PALO ALTO, CA  Stanford University School of Medicine, Stanford, CA  

Efficacy and Safety of Trofinetide in Patients with Rett Syndrome: A Systematic Review and Meta-analysis

Author:Abo Zeid, Mohamed   Elrosasy, Amr   Goufa, Elarbi   Ghazou, Alina   Hassan, Nourhan   Mohamed, Rashad Gamal   Negida, Ahmed   

Session Name:S37: Emerging Therapies in Child Neurology  

Topic:Child Neurology and Developmental Neurology  

Program Number:S37.002  

Author Institution:Faculty of Medicine Tanta University , Tanta, Egypt  Faculty Of Medicine, Cairo University, Cairo, Egypt, Cairo, Egypt  5. Faculty of Medicine, University of Oran 1 - Ahmed Ben Bella, Algeria, Sidi M'hamed Benali, Algeria  4. Faculty of Medicine, Jordan University of Science and Technology., Jordan, Jordan  6. Faculty of Medicine, Zagazig University, Egypt., Zagazig, Egypt  3. Mansoura Manchester Program for Medical Education, Faculty of Medicine, Mansoura University, Egypt., Bani Ebaid, Egypt  Virginia Commonwealth University, Richmond, VA  

Trofinetide for the Treatment of Girls Aged Two to Four Years with Rett Syndrome: Final Results from the Open-label DAFFODIL Study

Author:Percy, Alan   Ryther, Robin   Marsh, Eric   Feyma, Timothy   Lieberman, David   Neul, Jeffrey   Benke, Timothy   Glaze, Daniel   Berry-Kravis, Elizabeth   Ananth, Amitha   Buhrfiend, Colleen   An, Di   Darwish, Mona   Doshi, Dilesh   Bishop, Kathie   Youakim, James   

Session Name:S37: Emerging Therapies in Child Neurology  

Topic:Child Neurology and Developmental Neurology  

Program Number:S37.003  

Author Institution:University of Alabama at Birmingham, Birmingham, AL  Washington University School of Medicine, St Louis, MO  Children's Hospital of Philadelphia, Philadelphia, PA  Gillette Children's Specialty Healthcare, Saint Paul, MN  Boston Children's Hospital, Boston, MA  Vanderbilt University Medical Center, Nashville, TN  Children’s Hospital of Colorado/University of Colorado School of Medicine , Denver, CO  Baylor College of Medicine, Houston, TX  Rush University Medical Center, Chicago, IL  University of Alabama at Birmingham/Pediatric Neurology, Birmingham, AL  Acadia Pharmaceuticals, Inc., San Diego, CA  Acadia Pharmaceuticals, Inc., Malvern, PA  Acadia Pharmaceuticals, Inc., Princeton, NJ  

Genotype-phenotype Correlations and Sex Differences in ZC4H2-associated Rare Disorder (ZARD): Results from the ZARD Natural History Study

Author:Peters, Sydney   Sportiello, Kristen   Mandalapu, Shreya   Nguyen, Ashlie   Carrier, Ryan   Dickinson, Carolyn   Paciorkowski, Alexander   Bearden, David   

Session Name:S37: Emerging Therapies in Child Neurology  

Topic:Child Neurology and Developmental Neurology  

Program Number:S37.004  

Author Institution:University of Rochester School of Medicine and Dentistry, Rochester, NY  University of Rochester School of Arts and Sciences, Rochester, NY  Roberts Wesleyan University, Rochester, NY  University of Rochester, Rochester, NY  

Midazolam Versus Ketamine as the First-line Continuous Infusion for Status Epilepticus in Children with Congenital Heart Disease

Author:Javadian, Sam   Keenan, Julia   Liu, Yu-Ting   Voleti, Shruthi   Conley, Carolyn   Staso, Katelyn   Horvat, David   Schlatterer, Sarah   Sansevere, Arnold   Harrar, Dana   

Session Name:S37: Emerging Therapies in Child Neurology  

Topic:Child Neurology and Developmental Neurology  

Program Number:S37.005  

Author Institution:The George Washington University, Washington, DC  Children's National Hospital, Washington, DC  Children'S National Medical Center, Washington, DC